Ritsuo Nishiuchi Selected Research

Ritsuo Nishiuchi Research Topics

4	Leukemia 01/2022 - 10/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2003
2	Neoplasms (Cancer) 01/2015 - 06/2014
2	Lymphoma (Lymphomas) 12/2003 - 08/2002
1	Residual Neoplasm 01/2024
1	Respiratory Insufficiency (Respiratory Failure) 09/2022
1	Spontaneous Remission 01/2022
1	Hereditary Folate Malabsorption 11/2019
1	Uveitis 03/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2017
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 02/2016
1	Pneumococcal Infections 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Hydrocephalus (Hydrocephaly) 01/2015
1	Posterior Leukoencephalopathy Syndrome 01/2015
1	Philadelphia Chromosome 01/2014
1	Virus Diseases (Viral Diseases) 10/2012
1	Human Influenza (Influenza) 10/2012
1	Neoplasm Metastasis (Metastasis) 08/2004
1	Neuroblastoma 08/2004
1	Disease Progression 08/2004
1	Plasmacytoma 12/2003
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2003
1	B-Cell Leukemia (Leukemia, B Cell) 12/2003
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2003
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 12/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2003
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 08/2002

2	Phosphotransferases (Kinase)IBA 01/2014 - 10/2003
2	Messenger RNA (mRNA)IBA 08/2004 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 12/2003 - 10/2003
1	Etoposide (VP 16)FDA LinkGeneric 01/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024
1	nusinersenIBA 09/2022
1	ZolgensmaIBA 09/2022
1	RisdiplamIBA 09/2022
1	Proton-Coupled Folate TransporterIBA 11/2019
1	HLA-B51 AntigenIBA 03/2017
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2015
1	Bevacizumab (Avastin)FDA Link 01/2015
1	VaccinesIBA 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015
1	Conjugate VaccinesIBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 08/2004
1	EnzymesIBA 12/2003
1	hydrogen sulfite (bisulfite)IBA 12/2003
1	tanespimycin (17AAG)IBA 10/2003
1	herbimycinIBA 10/2003
1	Molecular Chaperones (Chaperone, Molecular)IBA 10/2003
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2003
1	E-SelectinIBA 08/2002
1	6-sulfo sialyl Lewis XIBA 08/2002

4	Therapeutics 01/2022 - 01/2003
2	Hematopoietic Stem Cell Transplantation 01/2024 - 03/2017
2	Drug Therapy (Chemotherapy) 03/2017 - 01/2015
1	Ventriculoperitoneal Shunt 01/2015
1	Laparotomy 06/2014
1	Ambulatory Care (Outpatient Care) 10/2012